Cyrus Desouza, MD
Enriched profileProfessor and Chief, Division of Diabetes, Endocrinology & Metabolism, Department of Internal Medicine, University of Nebraska Medical Center · University of Nebraska Medical Center (UNMC)
Cyrus Desouza is Professor and Chief, Division of Diabetes, Endocrinology & Metabolism, Department of Internal Medicine, University of Nebraska Medical Center at University of Nebraska Medical Center (UNMC). OpenAlex indexes 228 publications with 10,778 citations (h-index 38); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Cyrus V. Desouza, MD, is Professor and Chief, Division of Diabetes, Endocrinology & Metabolism, Department of Internal Medicine, University of Nebraska Medical Center. The public record shows 228 publications with 10,778 citations (h-index 38), centered on Obesity. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 14 companies, 2 NIH-funded awards (2009–2025).
- Most recent indexed publication: 2026 · Diabetes care
- Top research focus: Obesity
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Sponsor: Brigham and Women's Hospital
- The Role of Apathy in Glycemic Control
Sponsor: US Department of Veterans Affairs
- Role of Apathy in the Effectiveness of Weight Loss Interventions
Sponsor: VA Nebraska Western Iowa Health Care System
Industry payments
Updated 27 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20255 payments
- Eli Lilly and CompanyProgram year20251 payment
- Ascendis Pharma Endocrinology IncProgram year20251 payment
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2009–2025 per NIH RePORTER. The latest:
- All of Us Research Program Heartland Consortium (AoURP-HC)
University of Kansas Medical Center
FY2025$1,500,000OT2OD036430 - TP-R: a novel mediator of obesity-linked insulin resistance in humans
Omaha Va Medical Center
FY2025I01CX002084 - All of Us Research Program Heartland Consortium (AoURP-HC)
University of Kansas Medical Center
FY2024$2,800,000OT2OD036430
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial.
Diabetes care
Clinical Trial2026 - Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss.
Journal of clinical medicine
Review2026 - Efficacy and Hypoglycemia Profile of Once-weekly Insulin Icodec vs Once-daily Comparators Across Demographic Subgroups.
The Journal of clinical endocrinology and metabolism
Clinical Trial2025 - Lack of Association of Emotional Distress With Insulin Initiation in the GRADE Randomized Diabetes Comparative Effectiveness Trial.
The science of diabetes self-management and care
Clinical Trial2025 - Factors Associated with Response to SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Veterans with Type 2 Diabetes Mellitus.
Journal of clinical medicine
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/cyrus-desouza-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nebraskamed.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nebraskamed.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nebraskamed.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- Board Certified
Endocrinology, Diabetes and Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nebraskamed.com ↗
Editorial & leadership roles
journal and society appointments- Director
Diabetes & Obesity Program, Omaha VA Medical Center / VA Nebraska-Western Iowa Healthcare System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Director
UNMC Endocrinology Fellowship Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →unmc.edu ↗
Awards & honors
honors on the public record- FACP
Fellow, American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - FACE
Fellow, American College of Endocrinology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Secondary affiliations
appointments beyond the home institution- Omaha VA Medical Center (VA Nebraska-Western Iowa Healthcare System)
Director, Diabetes & Obesity Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Nebraska Medicine
clinical practice site, Diabetes and Endocrinology Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nebraskamed.com ↗
Media & interviews
press, podcasts and appearances- Video symposium series (3 CME videos on incretin-based/GLP-1 diabetes therapy)
iQ&A Medical Intelligence Zone, CMEducation Resources/BroadcastMed
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iqanda-cme.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesincontrol.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council